Every SEC Form 3/4/5 on record for this filer (CIK 1671311) — 11 issuers, 76 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| ZURA | Zura Bio Ltd | Director | 2023-03-21 → 2026-06-22 | 5 | — |
| SGMT | Sagimet Biosciences Inc. | Director | 2024-08-05 → 2026-06-15 | 4 | — |
| DMRA | Damora Therapeutics, Inc. | See Remarks · Director | 2026-04-01 → 2026-04-01 | 2 | — |
| SNDX | Syndax Pharmaceuticals Inc | Director | 2018-09-27 → 2026-02-06 | 10 | — |
| RCUS | Arcus Biosciences, Inc. | Chief Operating Officer | 2018-03-14 → 2026-01-26 | 40 | −$12M |
| RDUS | Radius Health, Inc. | Director · lapsed | 2022-05-20 → 2022-08-15 | 3 | — |
| ARNA | ARENA PHARMACEUTICALS INC | Director · lapsed | 2017-06-14 → 2022-03-11 | 7 | — |
| SRZN | Surrozen, Inc./DE | Filer · lapsed | 2021-08-13 → 2021-08-13 | 1 | — |
| CHFW | Consonance-HFW Acquisition Corp. | Director · lapsed | 2020-11-18 → 2020-11-18 | 1 | — |
| BOLD | Boundless Bio, Inc. | Director · lapsed | 2017-06-13 → 2020-01-15 | 6 | — |
| MDVN | MEDIVATION, INC. | Chief Financial Officer · lapsed | 2016-04-08 → 2016-09-30 | 3 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| RCUS | 2025-12-17 | Sell | 9,983 | $22.16 | $221,223 | 193,024 |
| RCUS | 2025-12-16 | Sell | 11,225 | $21.88 | $245,603 | 203,007 |
| RCUS | 2025-11-07 | Sell | 50,291 | $18.97 | $954,020 | 214,232 |
| RCUS | 2025-10-08 | Sell | 37,792 | $15.05 | $568,770 | 214,232 |
7 of 11 issuers are covered and open a security page; the rest are on file here only.
